Today’s solid yields are not only providing income to investors, they may also translate into higher total returns in the future, according to Wells Fargo.
Watch out: Analysts are getting increasingly bearish these stocks into earnings
Earnings season is underway, and some companies that are due to report earnings in the near future could post disappointing results, according to analysts.
Chubb’s Evan Greenberg says insurer just had the best year in its history
“While we’re in the risk business … we’re confident in our ability to continue growing operating earnings and EPS at a double-digit rate,” the CEO said.
How to keep profiting from this healthcare stock that’s breaking out
Tony Zhang gives an update on his successful Dexcom trade.
BlackRock’s Rick Rieder was a buyer of certain names during tech’s ‘watershed event’ this week
The market fallout from concerns over DeepSeek led to a buying opportunity in certain areas within tech, BlackRock’s Rick Rieder told CNBC.
The key figures Wall Street is watching for in Meta, Microsoft and Tesla earnings
Meta Platforms, Tesla and Microsoft are each set to report quarterly results after Wednesday’s market close.
Wall Street believes software stocks could be the big winner from the DeepSeek revelation
BMO Capital Markets listed three ideas within the software sector.
Oppenheimer downgrades Apple on weakening iPhone sales and worries around AI innovation
The firm downgraded Apple to perform from outperform and removed its $250 price target on the stock.
Here are Wednesday’s biggest analyst calls: Apple, Tesla, Nvidia, Microsoft, Walmart, Meta, Moderna, Starbucks & more
Here are Wednesday’s biggest calls on Wall Street.
Moderna gets a downgrade from Goldman Sachs on vaccine revenue struggles
Analyst Salveen Richter downgraded shares of the biotech company from neutral to buy and significantly lowered her price target.